A Disruptive Biotech mARKETPLACE

Clora

Clora

Market/Space
Biotech
Stage
6M Seed Funding + Sprinting to a
20M Series A
The Scope
  • Building Consistent Supply
  • Increasing Fulfillment Rate
  • Accelerating Deal Flow

BioPharma Post Pandemic

The pandemic revealed many vulnerabilities in a lot of different industries, however, it did the very opposite for the biotech space. It proved that with enough money and talent, any therapy could be accelerated to market. This conclusion alone disrupted an incumbent system ripe for change and the entire landscape of both resources and talent.

Clora stands at the helm - a two-sided marketplace matching talent and therapies with unprecedented precision, ease, and velocity.

The problem

A Non-commodity Transaction Cycle

Traditional growth tactics were very difficult to apply to the biotech industry.

The variability in resumes is vast and the purchasing behavior on the demand side is very fickle. For example, two deeply identical resumes could be received with a stark difference depending how a past employer chose to develop a therapy. This is why the railroads for hiring come from word-of-mouth and private networks. Couple that with anticipating talent needs - it’s an absolute nightmare.

A company’s talent needs can change in a moment’s notice or just as quickly enter a stall period.

Building Consistent Supply

Clora’s platform houses over 7K hyper-specialized, biotech consultants. It’s imperative to keep this “supply” very engaged and ready once the right opportunity presents a good fit. Like any marketplace dealing in placing talent, there will always be more supply than demand. So the problem to solve became - “how do we not only build a relationship with our supply beyond a transaction but how do we also speed up our ticket cycle”. Historically, these two beliefs were fundamentally at odds with one another.

Building a Competitive Advantage

After investigation, a specific handful of transactions revealed we could build a more holistic offense around consultants we deemed activated. They would be treated differently from the rest of our supply being queued up for a more expedited process. Our fulfillment team would keep them top of mind when spearheading new and existing deals.

Results

After collaborating with operations, sales, product, and marketing - we revamped and fast-tracked our transaction cycles. This increased metrics across the board from deal flow to supply utilization. It is the cornerstone of current fundraising efforts.

Johnny entered at a dubious time when an executive leader had just left. We were in need of some startup grit and resilience. He ushered in an unseen company-wide collaboration weaving together cross-departmental strategies into one holistic vision.

His locker room talks alone would be enough to be considered impressive. You add that to a clairvoyant + precise growth mindset and you have an invaluable resource.

Steve Fukuda
Head of Operations, Clora

View More Case Studies

View More Case Studies

More About Me